InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Plinio Mark D., Directeur Commercial. Insider active across 1 company, notably Evelo Biosciences, Inc.. Aggregated, 3 disclosures have been logged. History available since 31 January 2023. The latest transaction was filed on 31 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Plinio Mark D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
1,250 shares@ US$0.888.3% of flowCommon StockSEC:0001694665-23-000004:0
1,250 shares@ €1.756218.0% of flowCommon StockSEC:0001694665-22-000132:0
1,250 shares@ €3.589850.0% of flowCommon StockSEC:0001694665-22-000029:0
3 of 3 declarations
About Plinio Mark D.
Mark D. Plinio is the Chief Commercial Officer at Evelo Biosciences, Inc. He is responsible for the company's commercial strategy and sales development. His role is essential in maximizing market opportunities and supporting Evelo's growth.
